Seres Therapeutics MCRB Balance Sheet (2014-2026)

NASDAQ MCRB
$5.12 -0.16 (-3.03%)
As of: Sep 10, 2026 · 2:56 PM EDT
Reported Financials

Seres Therapeutics Quarterly Balance Sheet

Periods 49 quarters
Latest Jun 2026

Seres Therapeutics reported total assets of $101.59M and total liabilities of $67.05M for the quarter ended Jun 2026, down 29.4% year over year. This balance sheet covers 49 quarters of results from Jun 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Accumulated Depreciation
38.72M40.27M41.84M43.52M45.27M45.04M46.44M47.97M49.65M49.08M52.40M53.82M52.17M53.20M54.27M55.33M56.38M56.61M57.39M55.30M
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
353.18M180.00M248.00M195.79M233.00M163.03M94.84M229.52M169.91M127.97M111.18M71.23M66.82M30.79M58.85M45.38M47.64M45.77M29.83M15.59M
Receivables - NetNet Receivables
1.25M7.40M0.35M0.16M0.23M0.27M
Receivables - OtherOther Receivables
7.56M16.86M8.67M7.42M18.60M2.68M1.62M0.28M0.05M
Receivables
1.25M2.68M9.03M0.40M0.16M0.23M0.27M
Raw Materials
0.55M3.53M4.43M4.22M4.93M
Work In Process
4.75M14.99M25.22M37.27M48.06M
Finished Goods
0.04M0.48M
Inventory
5.34M18.52M29.65M41.97M53.00M
Prepaid Assets
10.17M12.92M15.25M13.79M14.51M13.42M9.54M8.82M9.10M8.05M4.61M6.43M6.10M5.81M4.47M2.42M3.11M3.09M1.77M1.48M
Current Assets
358.81M303.63M263.25M209.58M247.51M194.76M116.08M251.24M214.39M175.41M165.18M149.26M72.93M38.67M66.08M48.69M51.53M49.38M31.84M42.35M
Non-Current Assets
Property, Plant & Equipment (Net)
17.36M17.94M19.07M19.52M19.48M22.98M24.31M24.03M23.57M17.61M19.11M17.79M12.57M11.53M10.55M9.62M8.58M7.63M6.85M5.80M
Long-Term Investments
5.79M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M1.40M
Other Non-Current Assets
0.60M8.00M8.19M9.51M11.54M10.46M11.31M11.25M12.05M63.39M41.47M41.52M9.87M8.67M8.67M8.67M8.67M8.67M8.67M2.24M
Non-Current Assets
37.48M51.23M56.64M63.62M64.36M154.02M154.11M155.15M153.31M183.19M176.08M172.47M105.81M101.14M98.10M95.11M91.95M88.82M85.78M59.24M
Assets
396.29M354.86M319.89M273.20M311.87M348.78M270.19M406.39M367.70M358.60M341.26M321.73M178.74M139.81M164.18M143.80M143.47M138.19M117.62M101.59M
Liabilities
Current Liabilities
Accounts Payables
8.62M13.73M6.79M13.99M10.45M17.44M12.30M12.92M8.96M3.64M5.22M4.81M8.25M4.08M2.17M2.20M1.68M1.68M2.34M1.19M
Notes Payables
9.35M0.46M
Payables
17.97M13.73M6.79M13.99M10.45M17.90M12.30M12.92M8.96M3.64M5.22M4.81M8.25M4.08M2.17M2.20M1.68M1.68M2.34M1.19M
Accumulated Expenses
48.90M45.09M48.28M56.89M59.17M59.84M44.36M55.88M54.16M22.51M76.32M86.36M17.72M10.72M6.22M5.81M6.38M3.97M2.86M3.74M
Other Accumulated Expenses
1.63M3.63M1.45M5.45M4.13M3.64M6.48M7.95M2.93M2.77M1.99M4.26M6.69M2.16M2.63M1.04M1.51M0.90M0.64M0.95M
Current Leases
6.10M6.61M6.85M7.06M7.33M3.60M4.78M5.47M6.28M5.59M8.83M9.20M8.35M8.67M9.05M9.48M9.92M10.39M10.87M11.83M
Current Deferred Revenue
21.62M16.82M20.44M11.10M4.87M4.26M2.38M2.82M9.46M7.73M8.11M7.92M
Total Current Liabilities
94.59M82.26M82.36M89.04M81.82M85.60M63.82M77.90M79.22M98.66M98.48M108.28M64.83M41.22M31.32M30.94M22.43M19.32M19.34M20.03M
Non-Current Liabilities
Non-Current Debt
16.12M24.64M50.44M50.63M50.86M50.59M51.23M100.74M101.14M101.54M102.01M102.49M
Non-Current Deffered Revenue
89.41M87.00M81.88M90.01M92.80M92.43M94.83M94.93M95.06M95.36M95.36M95.36M
Preferred Stock Liabilities
Minority Interest
Liabilities from Discontinued Operations
109.43M
Operating Leases
12.23M17.96M20.35M19.52M17.85M107.94M106.69M106.71M104.86M91.65M103.34M100.94M85.27M82.97M80.50M77.96M75.33M72.58M69.63M44.82M
Non-Current Deferred Tax Liability
160.59M102.56M50.56M
Other Non-Current Liabilities
8.20M11.49M3.91M0.94M0.96M1.44M1.49M1.97M1.58M1.63M1.68M1.73M1.78M1.84M1.90M1.95M2.01M2.08M2.14M2.21M
Total Non-Current Liabilities
212.35M211.86M235.03M249.19M243.32M336.56M316.58M381.81M381.24M401.83M399.32M407.08M153.04M124.19M111.82M108.90M97.76M91.90M88.98M64.85M
Total Liabilities
220.56M223.35M238.93M250.14M244.28M338.00M318.06M383.77M382.82M403.46M401.00M408.81M154.82M126.03M113.72M110.85M99.78M93.97M91.12M67.05M
Shareholder's Equity
Total Debt
25.46M24.64M50.44M50.63M50.86M51.05M51.23M100.74M101.14M101.54M102.01M102.49M
Common Equity
175.74M131.51M80.96M23.06M67.58M10.78M-47.87M22.61M-15.12M-44.86M-59.74M-87.07M23.92M13.78M50.47M32.95M43.70M44.22M26.50M34.53M
Liabilities and Shareholders Equity
396.29M354.86M319.89M273.20M311.87M348.78M270.19M406.39M367.70M358.60M341.26M321.73M178.74M139.81M164.18M143.80M143.47M138.19M117.62M101.59M
Retained Earnings
-564.35M-614.35M-670.98M-735.71M-795.72M-864.51M-935.68M-889.13M-936.99M-978.24M-1018.37M-1051.24M-962.46M-978.10M-945.42M-965.27M-957.07M-972.40M-992.32M-987.74M
Preferred Shares
10.00M
Treasury Shares
2.39M2.47M2.27M2.08M0.11M